ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Weekly Subcutaneous Injections of SER-214 in Subjects With Parkinson's Disease (PD), to Determine the Safety, Tolerability and Pharmacokinetic (PK) Profile of SER-214

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02579473
Recruitment Status : Active, not recruiting
First Posted : October 19, 2015
Last Update Posted : October 4, 2017
Sponsor:
Information provided by (Responsible Party):
Serina Therapeutics